Table 2.
Cumulative incidence of attrition (in %) and nature of attrition among HIV-infected adults who entered pre-ART care of the Integrated HIV Care programme, Myanmar, 2011–2014
| Attrition | |||||
|---|---|---|---|---|---|
| Cumulative incidence | |||||
| Time interval after enrolment in pre-ART care | Total numbers | Deaths (% within attrition) | LTFUs (% within attrition) | Censored Patients (ART initiated, RFU) | Attrition (%) at end of interval (95% CI)a |
| 0–1 month | 1,602 | 638 (39.8) | 964 (60.2) | – | 14 (13–15) |
| 1–2 months | 629 | 321 (51) | 308 (49) | 2,099 | 20 (19–21) |
| 2–3 months | 382 | 202 (52.9) | 180 (47.1) | 2,251 | 25 (24–26) |
| 3–4 months | 321 | 119 (37.1) | 202 (62.9) | 851 | 31 (30–32) |
| 4–5 months | 165 | 92 (55.8) | 73 (44.2) | 424 | 35 (34–36) |
| 5–6 months | 104 | 50 (48.1) | 54 (51.9) | 300 | 37 (36–39) |
| 0.5–1 year | 266 | 93 (35) | 173 (65) | 864 | 46 (45–48) |
| 1–2 years | 170 | 46 (27.1) | 124 (72.9) | 574 | 56 (54–58) |
| 2–3 years | 57 | 13 (22.8) | 44 (77.2) | 249 | 64 (62–66) |
| 3–4 years | 16 | 11 (68.8) | 5 (31.3) | 111 | 70 (67–74) |
| >4 years | – | – | – | 19 | 70 (67–74) |
a
Cumulative failure till the end of specified interval; HIV, human immunodeficiency virus; ART, antiretroviral therapy; LTFU, loss-to-follow-up; RFU: retained in follow-up.